Since the GNB3 C825T polymorphism appears to be a useful marker to predict the relative risk of diseases, such as hypertension and stroke, this meta-analysis is better suited in a preventive aspect to identify certain genotypes that will be most likely to benefit from pharmacological interventions. Here, GNB3 is linked to Stroke.